» Articles » PMID: 17318265

Abnormal Thyroid Hormone Metabolism in Mice Lacking the Monocarboxylate Transporter 8

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2007 Feb 24
PMID 17318265
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

In humans, inactivating mutations in the gene of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8; SLC16A2) lead to severe forms of psychomotor retardation combined with imbalanced thyroid hormone serum levels. The MCT8-null mice described here, however, developed without overt deficits but also exhibited distorted 3,5,3'-triiodothyronine (T3) and thyroxine (T4) serum levels, resulting in increased hepatic activity of type 1 deiodinase (D1). In the mutants' brains, entry of T4 was not affected, but uptake of T3 was diminished. Moreover, the T4 and T3 content in the brain of MCT8-null mice was decreased, the activity of D2 was increased, and D3 activity was decreased, indicating the hypothyroid state of this tissue. In the CNS, analysis of T3 target genes revealed that in the mutants, the neuronal T3 uptake was impaired in an area-specific manner, with strongly elevated thyrotropin-releasing hormone transcript levels in the hypothalamic paraventricular nucleus and slightly decreased RC3 mRNA expression in striatal neurons; however, cerebellar Purkinje cells appeared unaffected, since they did not exhibit dendritic outgrowth defects and responded normally to T3 treatment in vitro. In conclusion, the circulating thyroid hormone levels of MCT8-null mice closely resemble those of humans with MCT8 mutations, yet in the mice, CNS development is only partially affected.

Citing Articles

Sciatic nerve analysis in thyroid hormone transporters Mct8 and Oatp1c1 knockout mice.

Mayerl S, Alcaide Martin A, Bauer R, Heuer H Eur Thyroid J. 2025; 14(1).

PMID: 39812369 PMC: 11825152. DOI: 10.1530/ETJ-24-0248.


Toward a treatment for thyroid hormone transporter MCT8 deficiency - achievements and challenges.

Markova B, Mayerl S, Heuer H Eur Thyroid J. 2024; 13(6).

PMID: 39485732 PMC: 11623285. DOI: 10.1530/ETJ-24-0286.


Brain Abnormalities in Young Single- and Double-Heterozygote Mice for Both Nkx2-1- and Pax8-Null Mutations.

Giacco A, Iervolino S, Cioffi F, Peluso T, Mercurio G, Roberto L Mol Neurobiol. 2024; 62(4):4023-4041.

PMID: 39375286 PMC: 11880048. DOI: 10.1007/s12035-024-04524-7.


Evaluation of MELD Scores and Thyroid Hormones as Prognostic Factors of Liver Cirrhosis.

Belu A, Nicoara A, Belu D, Circo E Medicina (Kaunas). 2024; 60(9).

PMID: 39336515 PMC: 11433705. DOI: 10.3390/medicina60091474.


Cone photoreceptor differentiation regulated by thyroid hormone transporter MCT8 in the retinal pigment epithelium.

Liu Y, Ng L, Liu H, Heuer H, Forrest D Proc Natl Acad Sci U S A. 2024; 121(30):e2402560121.

PMID: 39018199 PMC: 11287251. DOI: 10.1073/pnas.2402560121.


References
1.
Reyns G, Janssens K, Buyse J, Kuhn E, Darras V . Changes in thyroid hormone levels in chicken liver during fasting and refeeding. Comp Biochem Physiol B Biochem Mol Biol. 2002; 132(1):239-45. DOI: 10.1016/s1096-4959(01)00528-0. View

2.
Herzovich V, Vaiani E, Marino R, Dratler G, Lazzati J, Tilitzky S . Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. Horm Res. 2006; 67(1):1-6. DOI: 10.1159/000095805. View

3.
Friedrichsen S, Christ S, Heuer H, Schafer M, Mansouri A, Bauer K . Regulation of iodothyronine deiodinases in the Pax8-/- mouse model of congenital hypothyroidism. Endocrinology. 2003; 144(3):777-84. DOI: 10.1210/en.2002-220715. View

4.
Watase K, Zoghbi H . Modelling brain diseases in mice: the challenges of design and analysis. Nat Rev Genet. 2003; 4(4):296-307. DOI: 10.1038/nrg1045. View

5.
Friesema E, Ganguly S, Abdalla A, Manning Fox J, Halestrap A, Visser T . Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem. 2003; 278(41):40128-35. DOI: 10.1074/jbc.M300909200. View